Why the study?
Some patients on aspirin show higher than expected platelet reactivity partly due to a pro-oxidant milieu, prompting investigation into its correlation with redox function biomarkers in T2DM and HC.
Is high on-aspirin platelet reactivity associated with reduced superoxide dismutase activity in patients with Type 2 Diabetes Mellitus or primary hypercholesterolemia?
Is high on-aspirin platelet reactivity associated with reduced superoxide dismutase activity in patients with Type 2 Diabetes Mellitus or primary hypercholesterolemia?
In patients with Type 2 Diabetes Mellitus or primary hypercholesterolemia, impaired redox equilibrium characterized by decreased SOD activity is associated with a suboptimal response to aspirin.
Answers are grounded in this paper and cite their sources.
Oxidative stress may drive residual platelet reactivity on aspirin in T2DM/HC; hypothesis-generating and leaves open need for targeted trials.
Platelet hyperactivation is involved in the established prothrombotic condition of metabolic diseases such as Type 2 Diabetes Mellitus (T2DM) and familial hypercholesterolemia (HC), justifying the therapy with aspirin, a suppressor of thromboxane synthesis through the irreversible inhibition of cyclooxygenase-1 (COX-1), to prevent cardiovascular diseases. However, some patients on aspirin show a higher than expected platelet reactivity due, at least in part, to a pro-oxidant milieu. The aim of this study was to investigate platelet reactivity in T2DM (n = 103) or HC (n = 61) patients (aspirin, 100 mg/day) and its correlation with biomarkers of redox function including the superoxide anion scavenger superoxide dismutase (SOD) and the in vivo marker of oxidative stress urinary 8-iso-prostaglandin F2α. As results, in T2DM and HC subjects the prevalence of high on-aspirin platelet reactivity was comparable when both non-COX-1-dependent and COX-1-dependent assays were performed, and platelet reactivity is associated with a lower SOD activity that in a stepwise linear regression appears as the only predictor of platelet reactivity. To conclude, in T2DM and HC, similarly, the impairment of redox equilibrium associated with a decrease of SOD activity could contribute to a suboptimal response to aspirin.
No takes yet. Share an insight, caveat, or question.
Barale et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: